{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:18:31Z","timestamp":1759335511992},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T00:00:00Z","timestamp":1177372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T00:00:00Z","timestamp":1177372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s00432-007-0198-9","type":"journal-article","created":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T13:00:29Z","timestamp":1177333229000},"page":"533-538","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature"],"prefix":"10.1007","volume":"133","author":[{"given":"Gabriel","family":"Wcislo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Szarlej-Wcislo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cezary","family":"Szczylik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,24]]},"reference":[{"key":"198_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00019606-199704000-00005","volume":"6","author":"BA Alman","year":"1997","unstructured":"Alman BA, Pajerski ME, Diaz-Cano S et al (1997) Aggessive fibromatosis (desmoid tumor) is a monoclonal disorder. Diag Mol Pathol 6:98\u2013101","journal-title":"Diag Mol Pathol"},{"key":"198_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0046-8177(96)90221-X","volume":"27","author":"M Li","year":"1996","unstructured":"Li M, Cordon-Cardo C, Gerald WL et al (1996) Desmoid fibromatosis is a clonal process. Hum Pathol 27:939\u2013943","journal-title":"Hum Pathol"},{"key":"198_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1061::AID-CNCR9>3.0.CO;2-K","volume":"77","author":"T Bauernhofer","year":"1996","unstructured":"Bauernhofer T, Stoger H, Schmidt M et al (1996) Sequential treatment of reccurrent mesenteric desmoid tumor. Cancer 77:1061\u20131065","journal-title":"Cancer"},{"key":"198_CR4","first-page":"637","volume":"40","author":"MN Kulaylat","year":"1999","unstructured":"Kulaylat MN, Karakousis CP, Keaney CM et al (1999) Desmoid tumor: a pleiomorphic lesion Eur. J Surg Oncol 40:637\u2013645","journal-title":"J Surg Oncol"},{"key":"198_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/bjs.1800124618","volume":"12","author":"M Stewart","year":"1924","unstructured":"Stewart M, Monat T (1924) Fibroma of the abdominal wall. Br J Surg 12:355\u2013377","journal-title":"Br J Surg"},{"key":"198_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0360-3016(97)00845-6","volume":"40","author":"MA Spear","year":"1998","unstructured":"Spear MA , Jennings LC, Mankin HJ et al (1998) Individualizing management of aggressive fibromatosis. Int J Radiat Oncol Biol Phys 40:637\u2013645","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"198_CR7","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1002\/1097-0142(19871215)60:12<2863::AID-CNCR2820601202>3.0.CO;2-I","volume":"60","author":"WA HH Klein Miller","year":"1987","unstructured":"Klein WA Miller HH, Anderson M et al (1987) The use of indomethacin , sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial poliposis. Cancer 60:2863\u20132868","journal-title":"Cancer"},{"key":"198_CR8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archsurg.1978.01370200092018","volume":"113","author":"CP Karakousis","year":"1978","unstructured":"Karakousis CP, Berjian RA, Lopez R et al (1978) Mesenteric fibromatosis in Gardner`s syndrome. Arch Surg 113:998\u20131000","journal-title":"Arch Surg"},{"key":"198_CR9","first-page":"139","volume":"5","author":"EJ Gardner","year":"1953","unstructured":"Gardner EJ, Richards RC (1953) Multiple cutaneous and subcutaneous lesions occuringsimultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5:139\u2013147","journal-title":"Am J Hum Genet"},{"key":"198_CR10","first-page":"3171","volume":"61","author":"A Hoos","year":"2001","unstructured":"Hoos A, Lewis JJ, Antonescu CR et al (2001) Characterisation of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors. Cancer Res 61:3171\u20133175","journal-title":"Cancer Res"},{"key":"198_CR11","first-page":"29","volume":"151","author":"BA Ahman","year":"1997","unstructured":"Ahman BA, Li C, Pajerski ME et al (1997) Increased beta-catenin protein and somatic APC mutations in sporadic agressive fibromatosis (desmoid tumors). Am J Pathol 151:29\u201334","journal-title":"Am J Pathol"},{"key":"198_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0955-0674(99)80031-3","volume":"11","author":"Q Eastman","year":"1999","unstructured":"Eastman Q, Grosschedl R (1999) Regulation of LEF-1\/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11:233\u2013240","journal-title":"Curr Opin Cell Biol"},{"key":"198_CR13","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1073\/pnas.102657399","volume":"99","author":"SS Cheon","year":"2002","unstructured":"Cheon SS, Cheah AY, Turley S et al (2002) Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 99:6973\u20136978","journal-title":"Proc Natl Acad Sci USA"},{"key":"198_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/jor.1100140507","volume":"14","author":"BA Alman","year":"1996","unstructured":"Alman BA, Greel DA, Ruby LK et al (1996) Regulation of proliferation and platelet-derived growth factor expression in palmar fibromatosis (Dupuytren contracture) by mechanical strain. J Orthop Res 14:722\u2013728","journal-title":"J Orthop Res"},{"key":"198_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lab.2003.10.002","volume":"43","author":"KM Skubitz","year":"2004","unstructured":"Skubitz KM, Skubitz APN (2004) Gene expression in agressive fibromatosis. J Lab Clin Med 43:89\u201398","journal-title":"J Lab Clin Med"},{"key":"198_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/sj.bjc.6601661","volume":"90","author":"H Denys","year":"2004","unstructured":"Denys H, De Wever O, Nusgens B et al (2004) Invasion and MMP expession profile in desmoid tumors. Br J Cancer 90:1443\u20131449","journal-title":"Br J Cancer"},{"key":"198_CR17","first-page":"383","volume":"9","author":"S Higaki","year":"1995","unstructured":"Higaki S, Tateishi A, Ohno T et al (1995) Surgical treatment of extra-abdominal desmoid tumors (aggresiive fibromatosis). Int Orthop 9:383\u2013389","journal-title":"Int Orthop"},{"key":"198_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/bjs.1800820424","volume":"82","author":"JT Plukker","year":"1995","unstructured":"Plukker JT, van Oort I, Vermey A et al (1995) Aggressive fibromatosis (non-familial desmoid tumor) : Theraputic problems and the role of adjuvant rodiotherapy. Br J Surg 82:510\u2013514","journal-title":"Br J Surg"},{"key":"198_CR19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2106\/00004623-199606000-00007","volume":"78","author":"DJ Pritchard","year":"1996","unstructured":"Pritchard DJ, Nascimento AG, Petersen IA et al (1996) Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am 78:848\u2013854","journal-title":"J Bone Joint Surg Am"},{"key":"198_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/00016470310017785","volume":"74","author":"BPM Dalen","year":"2003","unstructured":"Dalen BPM, Bergh PM, Gunterberg UP (2003) Desmoid tumors. A clinical review of 30 patients with more than 20\u00a0year`s follow up. Acta Orthop Scand 74:455\u2013459","journal-title":"Acta Orthop Scand"},{"key":"198_CR21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.1999.17.1.158","volume":"17","author":"MT Ballo","year":"1999","unstructured":"Ballo MT, Zagars GK, Pollack A et al (1999) Desmoid tumor: prognostic factors and outcome after surgery, radiotion therapy, or combined surgery and radiation therapy. J Clin Oncol 17:158\u2013167","journal-title":"J Clin Oncol"},{"key":"198_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0167-8140(94)01483-J","volume":"34","author":"CN Catton","year":"1995","unstructured":"Catton CN, O`Sullivan B, Bell R et al (1995) Aggressive fibromatosis: optimisation of local management with a retrospective failure analysis. Radiother Oncol 34:17\u201322","journal-title":"Radiother Oncol"},{"key":"198_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/0959-8049(92)90125-L","volume":"28A","author":"G Schmitt","year":"1992","unstructured":"Schmitt G, Mills EED, Levin V et al (1992) Radiotherapy of aggressive fibromatosis. Eur J Cancer 28A:832\u2013835","journal-title":"Eur J Cancer"},{"key":"198_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-8140(86)80118-9","volume":"7","author":"R Kens","year":"1986","unstructured":"Kens R, Bartelnik H (1986) The role of radiotherapy in the treatment of desmoid tumors. Rradiother Oncol 7:1\u20135","journal-title":"Rradiother Oncol"},{"key":"198_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0360-3016(98)00285-5","volume":"42","author":"MT Ballo","year":"1998","unstructured":"Ballo MT, Zagars GK, Pollack A (1998) Radiation therapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 42:1007\u20131014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"198_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/bjs.1800570816","volume":"57","author":"WAF Mc Adam","year":"1970","unstructured":"Mc Adam WAF, Goligher JC (1970) he occurence of desmoids in patients with familial polyposis coli. Br J Surg 57:618\u2013631","journal-title":"Br J Surg"},{"key":"198_CR27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/ajcp\/77.6.681","volume":"77","author":"P Havry","year":"1982","unstructured":"Havry P, Reitamo JJ, Vihko R et al (1982) The desmoid tumor III. A biochemical and genetic analysis. Am J Clin Pathol 77:681\u2013685","journal-title":"Am J Clin Pathol"},{"key":"198_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0277-5379(86)90047-7","volume":"22","author":"CL Lim","year":"1986","unstructured":"Lim CL, Walker MY, Melita RR et al (1986) Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 22:583\u2013587","journal-title":"Eur J Cancer Clin Oncol"},{"key":"198_CR29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/0959-8049(92)90445-8","volume":"28A","author":"MD Brooks","year":"1992","unstructured":"Brooks MD, Ebbs SR, Colletta AA et al (1992) Desmoid tumors treated with tripenylethylenes. Eur J Cancer 28A:1014\u20131018","journal-title":"Eur J Cancer"},{"key":"198_CR30","first-page":"1523","volume":"309","author":"A Lanori","year":"1983","unstructured":"Lanori A (1983) Effect of progesterone on desmoid tumors (aggressive fibromatosis). N Engl J Med. 309:1523","journal-title":"N Engl J Med."},{"key":"198_CR31","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1210\/jcem-49-5-672","volume":"49","author":"RM Barone","year":"1979","unstructured":"Barone RM, Shamonki IM, Siteri PKD et al (1979) Inhibition of peripheral aromatization of androstendione et estrone in post-menopausal women with breast cancer using-testolactone. J Clin Endocrinol Metab 49:672\u2013676","journal-title":"J Clin Endocrinol Metab"},{"key":"198_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/0002-9610(91)91102-O","volume":"161","author":"WR Waddell","year":"1991","unstructured":"Waddell WR, Kirsch WM (1991) Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors. Am J Surg 161:416\u2013421","journal-title":"Am J Surg"},{"key":"198_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1073\/pnas.95.2.681","volume":"95","author":"TA Chan","year":"1998","unstructured":"Chan TA, Morin PJ, Vogelstin B et al (1998) Mechanisms underlaying non-steroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95:681\u2013686","journal-title":"Proc Natl Acad Sci USA"},{"key":"198_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF02053335","volume":"35","author":"K Tsukuda","year":"1992","unstructured":"Tsukuda K, Church JM, Jagelman DJ et al (1992) Noncytotoxic therapy for intra-abdominal desmoid tumor in patient with familial adenomatous polyposis. Dis Colon Rectum 35:29\u201333","journal-title":"Dis Colon Rectum"},{"key":"198_CR35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0360-3016(93)90501-L","volume":"26","author":"JC Acker","year":"1993","unstructured":"Acker JC, Bossen EH, Halperin EC (1993) The management of desmoid tumors. Int J Radiat Oncol Phys 26:851\u2013858","journal-title":"Int J Radiat Oncol Phys"},{"key":"198_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/028418699432680","volume":"38","author":"JO Fernberg","year":"1999","unstructured":"Fernberg JO, Brosjo O, Larsson O et al (1999) Interferon-induced remission in aggressive fibromatosis of the lower extremity. Acta Oncol 38:971\u2013972","journal-title":"Acta Oncol"},{"key":"198_CR37","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/1097-0142(19930401)71:7<2242::AID-CNCR2820710713>3.0.CO;2-0","volume":"71","author":"K Seiter","year":"1993","unstructured":"Seiter K, Kemeny N (1993) Successful treatment of a desmoid tumor with doxorubicin. Cancer 71:2242\u20132244","journal-title":"Cancer"},{"key":"198_CR38","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1002\/1097-0142(19931201)72:11<3244::AID-CNCR2820721118>3.0.CO;2-D","volume":"72","author":"SR Patel","year":"1993","unstructured":"Patel SR, Evans HL, Benjamin RS (1993) Combination chemotherapy in adult desmoid tumors. Cancer 72:3244\u20133247","journal-title":"Cancer"},{"key":"198_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00000421-199904000-00020","volume":"22","author":"AJ Weiss","year":"1999","unstructured":"Weiss AJ, Horowitz S, Lackman RD (1999) Therapy of desmoid tumors and fibromatosis using vinorelbine. Am J Clin Oncol 22:193\u2013195","journal-title":"Am J Clin Oncol"},{"key":"198_CR40","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1200\/JCO.1998.16.9.3021","volume":"16","author":"SX Skapiec","year":"1998","unstructured":"Skapiec SX, Hawk BJ, Hoffer FA et al (1998) Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol 16:3021\u20133027","journal-title":"J Clin Oncol"},{"key":"198_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/annonc\/mdg064","volume":"14","author":"J Janinis","year":"2003","unstructured":"Janinis J, Patriki M, Vini L et al (2003) The pharmacological treatment of aggressive fibromatosis: a systemic review. Ann Oncol 14:181\u2013190","journal-title":"Ann Oncol"},{"key":"198_CR42","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Drucker","year":"2001","unstructured":"Drucker BJ, Talpaz M, Resta DJ et al (2001) Efficacy and safety of a specific inhibitor of the BCR-Abl tyrosine kinase in chronic myelogenous leukemia. N Engl J Med. 344:1031\u20131037","journal-title":"N Engl J Med."},{"key":"198_CR43","first-page":"139","volume":"295","author":"E Buchdunger","year":"2000","unstructured":"Buchdunger E, Cioffi CL, Law N et al (2000) Abl protein tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295:139\u2013145","journal-title":"J Pharmacol Exp Ther"},{"key":"198_CR44","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1182\/blood.V90.12.4947","volume":"90","author":"M Carroll","year":"1997","unstructured":"Carroll M, Ohno-Jones S, Tamura S et al (1997) CGP57148 a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-Abl, TEL-Abl, and TEL-PDGFR fusion proteins. Blood 90:4947\u20134952","journal-title":"Blood"},{"key":"198_CR45","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1056\/NEJMoa020461","volume":"346","author":"GD Demetri","year":"2002","unstructured":"Demetri GD, von Mahren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 346:472\u2013480","journal-title":"N Engl J Med"},{"key":"198_CR46","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1182\/blood-2004-10-3967","volume":"105","author":"AL. Dewar","year":"2005","unstructured":"Dewar AL., Cambareri AC, Zannettino ACW et al (2005) Macrophage colony stimulating factor receptor, c-fms, is a novel terget of imatinib. Blood 105:3127\u20133132","journal-title":"Blood"},{"key":"198_CR47","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/cncr.11029","volume":"95","author":"J Mace","year":"2002","unstructured":"Mace J, Biermann JS, Sondak V et al (2002) Response to extraabdominal desmoid tumors to therapy with omatinib mesylate. Cancer 95:2373\u20132379","journal-title":"Cancer"},{"key":"198_CR48","first-page":"195","volume":"22","author":"CL Corless","year":"2003","unstructured":"Corless CL, Heinrich MC, Dimitrijevic S et al (2003) Correlation of imatinib response with activation of KIT and PDGF receptors in a variety of cancers: Results of the CSTIB2225 trial. Proc Am Soc Clin Oncol 22:195 (783 a)","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-007-0198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-007-0198-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-007-0198-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-007-0198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T07:36:11Z","timestamp":1652600171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-007-0198-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,24]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1007\/s00432-007-0198-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,24]]},"assertion":[{"value":"5 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}